Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Red light therapy is safe and effectively increases hair growth in women with hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Bald men are often viewed more negatively and as older than they really are.

Neurosteroids show promise for treating epilepsy and more research is needed.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Certain drugs that block specific enzymes can help treat prostate diseases.

A gene called HDAC9 might be a new factor in male-pattern baldness.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.